Early CAR T-cell therapy in relapsed/refractory large B-cell lymphoma is associated with lower hematotoxicity burden.

Blood Adv · 2026 · PMC13052050 · PMID 41411524

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

did not reach statistical significanceP = .09so close (0.05 < p ≤ 0.1)

These patients also showed lower 1-year PFS, although the difference did not reach statistical significance (40.0% vs 58.7%; P = .09; Figure 1 B), whereas 1-year OS was comparable (70.0% vs 76.9%; P = .36).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.